OnabotulinumtoxinA vs Sacral Neuromodulation for Urgency Incontinence-Reply.
Publication
, Journal Article
Amundsen, CL; Richter, HE; Wallace, D; Pelvic Floor Disorders Network
Published in: JAMA
February 7, 2017
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
February 7, 2017
Volume
317
Issue
5
Start / End Page
535 / 536
Location
United States
Related Subject Headings
- Urinary Incontinence, Urge
- Urinary Incontinence
- Humans
- General & Internal Medicine
- Electric Stimulation Therapy
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Amundsen, C. L., Richter, H. E., Wallace, D., & Pelvic Floor Disorders Network. (2017). OnabotulinumtoxinA vs Sacral Neuromodulation for Urgency Incontinence-Reply. JAMA, 317(5), 535–536. https://doi.org/10.1001/jama.2016.19566
Amundsen, Cindy L., Holly E. Richter, Dennis Wallace, and Pelvic Floor Disorders Network. “OnabotulinumtoxinA vs Sacral Neuromodulation for Urgency Incontinence-Reply.” JAMA 317, no. 5 (February 7, 2017): 535–36. https://doi.org/10.1001/jama.2016.19566.
Amundsen CL, Richter HE, Wallace D, Pelvic Floor Disorders Network. OnabotulinumtoxinA vs Sacral Neuromodulation for Urgency Incontinence-Reply. JAMA. 2017 Feb 7;317(5):535–6.
Amundsen, Cindy L., et al. “OnabotulinumtoxinA vs Sacral Neuromodulation for Urgency Incontinence-Reply.” JAMA, vol. 317, no. 5, Feb. 2017, pp. 535–36. Pubmed, doi:10.1001/jama.2016.19566.
Amundsen CL, Richter HE, Wallace D, Pelvic Floor Disorders Network. OnabotulinumtoxinA vs Sacral Neuromodulation for Urgency Incontinence-Reply. JAMA. 2017 Feb 7;317(5):535–536.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
February 7, 2017
Volume
317
Issue
5
Start / End Page
535 / 536
Location
United States
Related Subject Headings
- Urinary Incontinence, Urge
- Urinary Incontinence
- Humans
- General & Internal Medicine
- Electric Stimulation Therapy
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences